Safety, Efficacy, Tolerability and Pharmacokinetics of NNC 0070-0002-0182 in Overweight or Obese Male and Female Volunteers
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Novo Nordisk A/S
Related studies linked through entity extraction aliases.
Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes
- Status
- COMPLETED
- Phase
- N/A
Management of Hyperglycemia in the ER: A Randomized Clinical Trial of a Subcutaneous Insulin Aspart Protocol Coupled With Rapid Initiation of Basal Bolus Insulin Prior to Hospital Admission Versus Usual Care
- Status
- WITHDRAWN
- Phase
- PHASE4
Early Diagnosis of Diabetes Mellitus in Patients With Cystic Fibrosis
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of Insulin NPH Compared to a New Insulin Formulation in Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE2
Observational Study to Evaluate the Safety of Levemir® in Diabetes
- Status
- COMPLETED
- Phase
- N/A
Observational Study of Safety and Effectiveness of NovoMix® 30 for the Treatment of Diabetes
- Status
- COMPLETED
- Phase
- N/A
Observational Study of Type 2 Diabetes Patients Failing on Oral Anti-diabetic Agents Initiated on Levemir® or Insulatard®
- Status
- COMPLETED
- Phase
- N/A
The Copenhagen Insulin and Metformin Therapy Trial
- Status
- COMPLETED
- Phase
- PHASE4
Observational Study in Type 2 Diabetes Treated by an Intensive Insulin Treatment (ICT) Containing Once Daily Levemir® (Insulin Detemir)
- Status
- COMPLETED
- Phase
- N/A
Glycaemic Control and Quality of Care in Type 2 Diabetes on NovoMix® 30 Previously Treated With Mixtard® Insulins
- Status
- COMPLETED
- Phase
- N/A
Observational Study of Safety and Tolerability of Levemir™ FlexPen™ (Insulin Detemir) in the Treatment of Type 1 and Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- N/A
Evaluation of Levemir® for the Treatment of Type 1 and 2 Diabetes
- Status
- COMPLETED
- Phase
- N/A
Prevention of Clinical Onset of Type 1 Diabetes in High Risk First Degree Relatives
- Status
- COMPLETED
- Phase
- PHASE2
Use of Levemir® Improves Metabolic and Clinical Status in Cystic Fibrosis-related Diabetes (CFRD)
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Effect of Two Different Fasting Blood Glucose Targets on Glucose Control in Patients With Type 2 Diabetes Using Insulin Detemir Once Daily
- Status
- COMPLETED
- Phase
- PHASE4
Effect of Biphasic Insulin Aspart 50 on Blood Glucose Control in Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Incretin Physiology and Beta-cell Function Before and After Weight-loss
- Status
- TERMINATED
- Phase
- N/A
Efficacy and Safety of Biphasic Insulin Aspart 30 With Metformin in Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE4
Safety Follow-up on Children and Adolescents With Type 1 Diabetes Treated With Insulin Detemir. An Extension to Trial NN304-1689
- Status
- COMPLETED
- Phase
- PHASE3